Welcome Message

To accelerate the adoption of this technology in clinical practice across Asia, Taiwan has received official support from MSACL (Mass Spectrometry & Advances in the Clinical Lab), the world’s most influential clinical mass spectrometry organization, to host the inaugural Clinical Mass Spectrometry Conference in Asia 2026 (CMSCA 2026). Centered on education and outreach, the conference will invite leading experts in clinical mass spectrometry to share their experience, helping the scientific and clinical communities strengthen this rapidly growing field. The conference will also invite distinguished plenary speakers, including Nobel laureate Koichi Tanaka, who pioneered soft laser desorption/ionization techniques that revolutionized biomolecular mass spectrometry, and Academician Yu-Ju Chen, a leading expert in proteomics and precision medicine and a recipient of the Taiwan Outstanding Women Scientists Award – Outstanding Award, whose work has significantly advanced translational applications of mass spectrometry in clinical research. The scientific program will comprehensively cover key areas driving the future of clinical mass spectrometry, including small molecules, hormones and endocrine analysis, therapeutic drug monitoring, toxicology, biomarkers, rare diseases and inborn errors of metabolism, as well as emerging fields such as artificial intelligence in the clinical laboratory, MALDI and imaging mass spectrometry, proteomics, metabolomics, lipidomics, clinical pharmacokinetics and pharmacodynamics, and method development and validation. Through deep collaboration with MSACL, the event will introduce the latest global technologies and application trends, enhancing healthcare quality. We warmly welcome researchers, clinical professionals, laboratory professionals, and industry partners to register and participate in this landmark conference in 2026.

隨著精準醫療的快速發展，質譜技術已成為臨床診斷與藥物開發中不可或缺的工具。其高靈敏度與高選擇性不僅提升診斷準確度，也使個人化治療策略得以實現。此技術在癌症診斷、生物標誌物探索、代謝疾病分析，以及藥物療劑監測等領域展現高度潛力。

為加速此技術在亞洲臨床領域的推廣應用，台灣已獲得全球最具影響力之臨床質譜組織 MSACL（Mass Spectrometry & Advances in the Clinical Lab）的正式支持，將於2026 年主辦首屆「亞洲臨床質譜會議」。本次會議以教育與推廣為核心，透過專家分享臨床質譜之實務經驗，協助各單位持續精進這個快速發展的領域。會議亦將邀請重量級大會講者，包括以開創soft laser desorption/ionization techniques技術革新生物分子質譜分析而獲得諾貝爾獎的田中耕一（Koichi Tanaka），以及在蛋白質體學與精準醫療領域具國際領導地位、並榮獲「台灣傑出女科學家獎—傑出獎」的陳玉如教授（Yu-Ju Chen），兩位講者的卓越成就將為會議帶來深度與啟發。

本次科學計畫將全面涵蓋臨床質譜的關鍵領域，包括小分子、荷爾蒙與內分泌分析、治療藥物監測、毒理學、生物標誌物、罕見疾病與先天性代謝異常，以及人工智慧於臨床實驗室之應用、MALDI 與影像質譜、蛋白質體學、代謝體學、脂質體學、臨床藥物動力學與藥效動力學，以及方法開發與驗證等主題。透過與 MSACL 的深度合作，本會議將引入全球最新技術與應用趨勢，以提升醫療品質為最終目標。我們誠摯歡迎研究人員、臨床醫事人員、實驗室專業人士與產業夥伴踴躍報名參加，共同參與這場2026 年的重要盛會。